摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,3S,4R,5S)-3-tetrahydropyranyl-4-hydroxymethyl-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)bicyclo[3.1.0]hexane | 873780-50-8

中文名称
——
中文别名
——
英文名称
(1S,3S,4R,5S)-3-tetrahydropyranyl-4-hydroxymethyl-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)bicyclo[3.1.0]hexane
英文别名
1-[(1S,3S,4R,5S)-4-(hydroxymethyl)-3-(oxan-2-yloxy)-1-bicyclo[3.1.0]hexanyl]pyrimidine-2,4-dione
(1S,3S,4R,5S)-3-tetrahydropyranyl-4-hydroxymethyl-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)bicyclo[3.1.0]hexane化学式
CAS
873780-50-8
化学式
C16H22N2O5
mdl
——
分子量
322.361
InChiKey
VRVSRGBPGZAANB-RNLIKJQXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    88.1
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1S,3S,4R,5S)-3-tetrahydropyranyl-4-hydroxymethyl-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)bicyclo[3.1.0]hexane四氮唑N,N'-羰基二咪唑三氟乙酸 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 54.75h, 生成 (1S,3S,4R,5S)-3-hydroxy-4-diphosphoroxymethyl-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)bicyclo[3.1.0]hexane
    参考文献:
    名称:
    Human P2Y6 Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
    摘要:
    Combining molecular dynamics (MD) in a hydrated phospholipid (DOPC) bilayer, a Monte Carlo search, and synthesis of locked nucleotide analogues, we discovered that the Southern conformation of the ribose is preferred for ligand recognition by the P2Y(6) receptor. 2'-Deoxy-(S)-methanocarbaUDP was found to be a full agonist of the receptor and displayed a 10-fold higher potency than that for the corresponding flexible 2'-deoxyUDP. MD results also suggested a conformational change of the second extracellular loop consequent to agonist binding.
    DOI:
    10.1021/jm050911p
  • 作为产物:
    描述:
    (1S,3S,4R,5S)-3-hydroxy-4-tert-butyldiphenylsilyloxymethyl-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)bicyclo[3.1.0]hexane 在 四丁基氟化铵对甲苯磺酸 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 2.0h, 生成 (1S,3S,4R,5S)-3-tetrahydropyranyl-4-hydroxymethyl-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)bicyclo[3.1.0]hexane
    参考文献:
    名称:
    Human P2Y6 Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
    摘要:
    Combining molecular dynamics (MD) in a hydrated phospholipid (DOPC) bilayer, a Monte Carlo search, and synthesis of locked nucleotide analogues, we discovered that the Southern conformation of the ribose is preferred for ligand recognition by the P2Y(6) receptor. 2'-Deoxy-(S)-methanocarbaUDP was found to be a full agonist of the receptor and displayed a 10-fold higher potency than that for the corresponding flexible 2'-deoxyUDP. MD results also suggested a conformational change of the second extracellular loop consequent to agonist binding.
    DOI:
    10.1021/jm050911p
点击查看最新优质反应信息

文献信息

  • Human P2Y<sub>6</sub> Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
    作者:Stefano Costanzi、Bhalchandra V. Joshi、Savitri Maddileti、Liaman Mamedova、Maria J. Gonzalez-Moa、Victor E. Marquez、T. Kendall Harden、Kenneth A. Jacobson
    DOI:10.1021/jm050911p
    日期:2005.12.1
    Combining molecular dynamics (MD) in a hydrated phospholipid (DOPC) bilayer, a Monte Carlo search, and synthesis of locked nucleotide analogues, we discovered that the Southern conformation of the ribose is preferred for ligand recognition by the P2Y(6) receptor. 2'-Deoxy-(S)-methanocarbaUDP was found to be a full agonist of the receptor and displayed a 10-fold higher potency than that for the corresponding flexible 2'-deoxyUDP. MD results also suggested a conformational change of the second extracellular loop consequent to agonist binding.
查看更多

同类化合物

顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质1 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物 恩曲他滨 恩曲他滨 怀俄苷三乙酸酯 怀俄苷 己二酸,聚合1,2-丁二醇 外消旋拉米夫定酸 吡唑霉素 司他夫定 反式-阿巴卡韦盐酸盐 卡波啶 卡巴韦